XBIOTECH INC (XBIT) Forecast, Price Target & Analyst Ratings
NASDAQ:XBIT • CA98400H1029
2.34 USD
+0.02 (+0.86%)
Last: Mar 3, 2026, 08:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for XBIOTECH INC (XBIT).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateMar 16, 2026
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $2.34 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
XBIT was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about XBIT.
In the previous month the buy percentage consensus was at a similar level.
XBIT was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 16, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 44M | 18.39M -58.20% | 4.01M -78.19% | N/A -100.00% | N/A | |
| EBITDA YoY % growth | -16.04M 44.44% | -22.43M -39.84% | -31.88M -42.13% | N/A -12.19% | N/A -12.55% | |
| EBIT YoY % growth | -18.28M 41.47% | -25.08M -37.20% | -34.49M -37.52% | N/A -8.76% | N/A -11.97% | |
| Operating Margin | -41.55% | -136.38% | -860.10% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
XBIOTECH INC / XBIT Forecast FAQ
Can you provide the upcoming earnings date for XBIOTECH INC?
XBIOTECH INC (XBIT) will report earnings on 2026-03-16.
What is the consensus rating for XBIOTECH INC (XBIT) stock?
The consensus rating for XBIOTECH INC (XBIT) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.